Here are the FTSE stocks I bought last week

While other investors have been panicking, Edward Sheldon has been buying these FTSE stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While many investors are panicking about the stock market decline we’re experiencing right now, I’m seeing the drop as a buying opportunity. Sure, stocks could fall further, but I’m convinced that buying now, while the market is depressed, will pay off in five years’ time. With that in mind, here’s a look at three FTSE stocks I bought for my portfolio last week.

Smith & Nephew

The first stock I bought was Smith & Nephew (LSE: SN), which is a leading medical technology company that specialises in joint replacement systems, advanced wound management solutions, and surgical robotics. I first added the FTSE 100 stock to my portfolio a few weeks back and took the opportunity to buy more last week at lower share prices.

In the short term, I do expect SN to be impacted by the coronavirus. That’s because many elective surgeries are likely to be postponed in the near term. Yet in the long run, the growth story looks attractive. With the number of people aged 65 or over across the world set to increase from less than 1bn to over 2bn between now and 2050, demand for both joint replacement systems and wound care solutions is likely to increase.

Smith & Nephew shares have taken an enormous hit over the last month, falling from around 2,000p down to just 1,100p. That’s pushed the prospective dividend yield up to about 3%. At that price and yield, I’m a buyer.

JD Sports Fashion

The next stock I added was JD Sports Fashion (LSE: JD), the retailer of fashionable sportswear and trainers.

There’s no doubt that JD’s growth will be impacted by the coronavirus in the short term. Hardly any people out shopping translates to much lower sales for retailers. And if we see the expected recession, discretionary income will decrease, potentially meaning lower demand for non-essentials such as trainers.

However, the FTSE company does now have a strong online presence, which should help in the current environment. And I do not expect demand for JD’s products, such as Nike trainers, to fall off a cliff. During the Global Financial Crisis, the company still managed to generate like-for-like revenue growth.

JD’s share price has been smashed over the last month, falling from around 870p to under 300p. At the 300p level, I think the medium-to-long-term risk/reward proposition is highly attractive.

ASOS

Finally, I also added to my position in FTSE AIM 100 online fashion retailer ASOS (LSE: ASC). Its share price has fallen from around 3,300p to near 1,000p over the last month – a level that was last seen in 2012. Back then, revenue was £553m. Last year, revenue was £2.7bn.

Of course, like JD Sports, ASOS could see its near-term growth hampered by the coronavirus. For example, fewer people taking holidays as the weather warms up is likely to translate to lower demand for summer/beachwear, let alone general unwillingness to spend on fashion. 

Yet the long-term story remains attractive here. In my view, the company has developed one of the leading online fashion platforms in the world and as online sales continue to grow in the years ahead, ASOS should benefit. The potential for international growth also remains vast.

In the near term, I expect ASOS shares to be volatile. However, I’m confident that buying now will turn out to be a good move down the track.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in Smith & Nephew, JD Sports Fashion, and ASOS. The Motley Fool UK owns shares of and has recommended ASOS and Nike. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »